Rapamycin reduces rejection in heart transplant recipients

Transplant Proc. 2001 Nov-Dec;33(7-8):3221-2. doi: 10.1016/s0041-1345(01)02370-3.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Ethnicity
  • Female
  • Graft Rejection / prevention & control*
  • Heart Transplantation / immunology*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Sirolimus / therapeutic use*
  • Texas

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Sirolimus